Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
   
  HOME >> PRODUCTS >> Generic Medicines >> Taj Generics >> Page 7 >> Glimepiride Tablets
 
  Glimepiride Tablets  

 

 


COMPOSITION :
Glimepiride 1
Each tablet contains
Glimepiride……………….. ……………………………………1 mg
Excipients………....………………………………… …………q.s.

Glimepiride 2
Each tablet contains
Glimepiride……………….. ……………………………………2 mg
Excipients………....………………………………… …………q.s.

Glimepiride 4
Each tablet contains
Glimepiride……………….. ……………………………………4mg
Excipients………....………………………………… …………q.s.

      For more information, please see Full Prescribing Information.

INDICATIONS :
Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with non insulin-dependent (Type 2) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone. Glimepiride may be used concomitantly with metformin when diet, exercise, and glimepiride or metformin alone do not result in adequate glycaemic control.

Glimepiride is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycaemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycaemic agent. Combined use of glimepiride and insulin may increase the potential for hypoglycaemia.

DOSAGE AND ADMINISTRATION :
General
Dosage should be individualized on the basis of both effectiveness and tolerance. There is no fixed dosage regimen for the management of diabetes mellitus with glimepiride or any other hypoglycaemic agent.

Usual Starting Dose
The usual starting dose of Glimepiride as initial therapy is 1-2 mg once daily, administered with breakfast or the first main meal. Those patients who may be more sensitive to hypoglycaemic drugs should be started at 1 mg once daily, and should be titrated carefully.

No exact dosage relationship exists between glimepiride and the other oral hypoglycaemic agents. The maximum starting dose of Glimepiride should be no more than 2 mg. Failure to follow an appropriate dosage regimen may precipitate hypoglycaemia. Patients who do not adhere to their prescribed dietary and drug regimen are more prone to exhibit unsatisfactory response to therapy.

Usual Maintenance Dose
The usual maintenance dose is 1 to 4 mg once daily. The maximum recommended dose is 8 mg once daily. After reaching a dose of 2 mg, dosage increases should be made in increments of no more than 2 mg at 1-2 week intervals based upon the patient`s blood glucose response. Long-term efficacy should be monitored by measurement of HbA 1c levels, for example, every 3 to 6 months.

Glimepiride-Metformin Combination Therapy
If patients do not respond adequately to the maximal dose of Glimepiride monotherapy, addition of metformin may be considered. Published clinical information exists for the use of other sulphonylureas including glyburide, glipizide, chlorpropamide, and tolbutamide in combination with metformin.

With concomitant glimepiride and metformin therapy, the desired control of blood glucose may be obtained by adjusting the dose of each drug. However, attempts should be made to identify the minimum effective dose of each drug to achieve this goal. With concomitant glimepiride and metformin therapy, the risk of hypoglycaemia associated with glimepiride therapy continues and may be increased. Appropriate precautions should be taken.

Glimepiride-Insulin Combination Therapy
Combination therapy with glimepiride and insulin may also be used in secondary failure patients. The fasting glucose level for instituting combination therapy is in the range of >150 mg/dL in plasma or serum depending on the patient. The recommended glimepirde dose is 8 mg once daily administered with the first main meal. After starting with low-dose insulin, upward adjustments of insulin can be done approximately weekly as guided by frequent measurements of fasting blood glucose. Once stable, combination-therapy patients should monitor their capillary blood glucose on an ongoing basis, preferably daily. Periodic adjustments of insulin may also be necessary during maintenance as guided by glucose and HbA 1c levels.

CONTRAINDICATIONS :
Glimepiride is contraindicated in patients with
1. Known hypersensitivity to the drug.
2. Diabetic ketoacidosis, with or without coma. This condition should be treated with
insulin

PACKAGING INFORMATION :
Glimepiride 1 ..............Strip of 10 tablets
Glimepiride 2 ..............Strip of 10 tablets
Glimepiride 3 ..............Strip of 10 tablets

Wallpapers :     Glimepiride
     CLICK ON PHOTO TO SEE LARGE


 

product enquiry product quotation sample request order now
Product Enquiry Product Quotation Sample Request Order Now
       
       
   Information about Generic Medicines   career
   Information about Manufacturing   career
 

Glimepiride Tablets

Glimepiride Tablets
Pharmaceuticals Generics
  Topiramate Tablets  
  Atenolol 50 mg
Tablet
 
  Simvastatin 20mg Tablets  
  Carbamazepine Tablets  
  Omeprazole Capsule  
  Piracetam 800mg Tablets  
  Bisoprolol Tablets  
  Glimepiride Tablets  
  Acetyl Salicylic Acid Tablets  
  Metformin – Glibenclamide Tablet  
  Phentyoin Sodium Tablets  
  Molsidomine 2mg / 4mg Tablets  
  Albendazole Tablets  
 

More..

 
















































             
 Print page   Send by mail

 

 

 

 

 

 

 

  Glimepiride tablets 1mg 2mg 4mg Glimepiride fumrate tablets manufacturer (Generics) exporter Glimepiride tablets manufacturing composition drugs importer generic medicines Glimepiride fumrate tablets Capsules Injections api association processes possibilities absorption supplier metabolism injection exporter Method preparing Glimepiride tablets manufacturing Taj Pharmaceuticals Ltd. Glimepiride tablets Glimepiride fumrate tablets manufacturer India Exporter India Glimepiride fumrate tablets Capsules Injections Gelatin Glimepiride tablets BP 50mg Glimepiride tablets Glimepiride fumrate tablets India manufacturer exporter Glimepiride fumrate tablets Capsules Injections Trading supplier export import trader Generic drugs Glimepiride tablets Glimepiride fumrate tablets India manufacturer exporter Glimepiride fumrate tablets Capsules Injections Trading supplier export import trader Generic drugs Manufacturer manufacturing possibilities active ingredients medicine health uses trials Glimepiride tablets manufacturing process Glimepiride tablets possilibities India trading Glimepiride tablets supplier supply suppliers vendor vendors price prices Glimepiride tablets  
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

`



























 
































 

 
 www.tajpharma.com

   

 

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement